Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Cash & Current Investments (2017 - 2025)

Historic Cash & Current Investments for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $806886.0.

  • Selectis Health's Cash & Current Investments fell 373.85% to $806886.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $806886.0, marking a year-over-year decrease of 373.85%. This contributed to the annual value of $680332.0 for FY2024, which is 5417.4% down from last year.
  • Selectis Health's Cash & Current Investments amounted to $806886.0 in Q3 2025, which was down 373.85% from $771940.0 recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Cash & Current Investments registered a high of $4.0 million during Q4 2021, and its lowest value of $680332.0 during Q4 2024.
  • Over the past 5 years, Selectis Health's median Cash & Current Investments value was $1.0 million (recorded in 2023), while the average stood at $1.7 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 28707.55% in 2021, then tumbled by 7647.01% in 2022.
  • Selectis Health's Cash & Current Investments (Quarter) stood at $4.0 million in 2021, then plummeted by 39.03% to $2.4 million in 2022, then tumbled by 38.57% to $1.5 million in 2023, then crashed by 54.17% to $680332.0 in 2024, then grew by 18.6% to $806886.0 in 2025.
  • Its Cash & Current Investments stands at $806886.0 for Q3 2025, versus $771940.0 for Q2 2025 and $1.3 million for Q1 2025.